Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians

Published:2022-04-03 Issue:4 Volume:15 Page:305-320
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Kampouri Eleftheria¹²^ORCID,Walti Carla S.¹³,Gauthier Jordan⁴⁵,Hill Joshua A.¹⁴⁵^ORCID

Affiliation:

1. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

2. Department of Medicine, Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

3. Infectious Disease and Hospital Epidemiology Division, University Hospital Basel, Basel, Switzerland

4. Department of Medicine, University of Washington, Seattle, Washington, USA

5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2063833

Reference105 articles.

1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

2. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

4. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

5. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

2. Prérequis et organisation du parcours de soins en vue de l’utilisation d’une thérapie cellulaire ou génique par cellules stromales mésenchymateuses (CSM) ou par cellules T porteuses d’un récepteur antigénique chimérique (CAR-T cells) chez les patients avec maladies auto-immunes systémiques;Bulletin du Cancer;2024-09

3. Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities;Intensive Care Medicine;2024-08-22

4. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence;Blood Advances;2024-08-14

5. Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing;Molecular Therapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3